About
Solutions
Pipeline
Publications
News
Careers
Contact Us
en
Open main menu
News
Loading...
CN
MindRank has Nominated Kinase Inhibitors as Preclinical Candidates with the Potential to be Best-in-Class for IND-Enabling Studies
2023-11-23
The original news link in Chinese:
「德睿智药」提名潜在同类最优激酶抑制剂候选药物，开展IND-ENABLING研究
News - MindRank
Previois
Back
Next
